Vinati Organics (VINATIORGA)

FairStock Score: 51/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Zero debt with ROE of 18.49% and ROCE of 20.61% reflects a capital-efficient, financially resilient business
• Promoter holding of 74.29% aligns management interests with minority shareholders
• Proven long-term track record with a 5-year revenue CAGR of 18.70%
• Profit growth of 13.52% despite near-flat sales suggests pricing power or margin discipline
• Piotroski F-Score of 7/9 indicates sound overall financial health

Concerns

• High valuation: P/E of 31.94, P/B of 5.21, and PEG of 3.04 leave little margin of safety
• Latest sales growth is only 1.43%, a sharp slowdown from the 5-year revenue CAGR
• Free cash flow of ₹15 Cr is drastically lower than net profit of ₹108 Cr, raising doubts about earnings quality
• Dividend yield of 0.51% provides negligible income cushion at the current price

AI Analysis

Vinati Organics is a well-run, debt-free speciality chemical business. The 18.49% return on equity and 20.61% ROCE tell me that capital is being deployed sensibly, and 74.29% promoter holding keeps interests aligned. That part I like. But as Graham would say, valuation is where discipline begins. At ₹1,299 per share, the market cap is ₹15,261 crore, which works out to a P/E of 31.94 and P/B of 5.21. Paying more than five times book value for a company earning 18.49% on equity leaves little room for error. The five-year revenue CAGR of 18.70% shows the past was excellent, but the latest sales growth is only 1.43%. Profit still rose 13.52%, which suggests margin expansion is doing the heavy lifting. I cannot rely on margin improvement forever unless sales volume returns. More troubling, free cash flow is only ₹15 crore against net profit of ₹108 crore. That gap is significant and makes me question how much of this profit is real cash. The Piotroski score of 7 out of 9 is decent, and zero debt gives the company resilience. But the dividend yield of 0.51% offers no income cushion, and with a PEG ratio of 3.04, the market is expecting very high future growth. This may be a wonderful company, but at this price it is not a wonderful investment. I need margin of safety, and today the stock price near the lower end of its 52-week range might look tempting, but cheapness is not the same as value. I would need either a lower price or proof of renewed volume growth and better cash conversion before I commit capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer